Alzheimer Europe company information, Employees & Contact Information

ADI - European Commission approves first disease-modifying treatment for Alzheimer’s disease in the EU Alzheimer's Disease International (ADI)

Informed consent in dementia research: how Public Involvement can contribute to addressing “old” and “new” challenges Frontiers

Lilly's Kisunla receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease Investing News Network

A Comparative Analysis of Dementia Strategies of Fifteen European Countries in the Context of Glasgow Declaration and WHO’s Global Action Plan medRxiv

Cure Parkinson’s and Alzheimer’s Research UK announce new partnership Parkinson's Europe

Breakthrough Alzheimer's Treatment Donanemab Gets Crucial European Backing for 6.9M Patient Market Stock Titan

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease Biogen

New Alzheimer Europe publication highlights continuing inequalities in access to dementia care and treatment across Europe EurekAlert!

Economic costs of dementia in 11 countries in Europe: Estimates from nationally representative cohorts of a panel study The Lancet

European consensus for the diagnosis of MCI and mild dementia: Preparatory phase Wiley

Considering inequities in national dementia strategies: breadth, depth, and scope International Journal for Equity in Health

News at a glance: Europe rejects Alzheimer’s drug, cancers rise in young Americans, and NASA finds a promising Mars rock Science | AAAS

ADI - Alzheimer Europe 2024: New Horizons – Innovating for dementia Alzheimer's Disease International (ADI)

International Working Group publishes revised diagnostic criteria for Alzheimer’s disease EurekAlert!

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union Biogen

Keeping track of and recognizing the value of Public Involvement work in dementia research Frontiers

ADI - 33rd Alzheimer Europe Conference Alzheimer's Disease International (ADI)

Attitudes toward pre-symptomatic screening for Alzheimer’s dementia in five European countries: a comparison of family members of people with Alzheimer’s dementia versus non-family members Frontiers

ADI - October Highlights: ADI’s Key Engagements in Dementia Advocacy Across Europe Alzheimer's Disease International (ADI)

Regions Alzheimer's Disease International (ADI)

Advancing dementia care in Pakistan: challenges and the way forward Frontiers

Global and regional spending on dementia care from 2000–2019 and expected future health spending scenarios from 2020–2050: An economic modelling exercise ScienceDirect.com

Europe sidelines Alzheimer’s drug: lessons must be learnt Nature

Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer’s disease: how and what to tell. A kickstart to an ethical discussion Frontiers

Transferability of European-derived Alzheimer’s disease polygenic risk scores across multiancestry populations Nature

Assessing the cognitive decline of people in the spectrum of AD by monitoring their activities of daily living in an IoT-enabled smart home environment: a cross-sectional pilot study Frontiers

Living with dementia in a care home: facilitating participation in activities Frontiers

European perspectives on dementia prevention: Can lifestyle changes reduce risk? Open Access Government

Wearable Devices for Assessing Function in Alzheimer's Disease: A European Public Involvement Activity About the Features and Preferences of Patients and Caregivers Frontiers

Twenty-seven-year time trends in dementia incidence in Europe and the United States Neurology® Journals

α-Lipoic acid: a potential regulator of copper metabolism in Alzheimer’s disease Frontiers

Number of people with dementia is set to double by 2050, according to new report Medical Xpress

Performance of probable dementia classification in a European multi-country survey | Scientific Reports Nature

How is migration background considered in the treatment and care of people? A comparison of national dementia care guidelines in Europe BMC Public Health

Dementia epidemiology in Hungary based on data from neurological and psychiatric specialty services Nature

Editorial: Neurocognitive disorders and depression—Complex interrelationships Frontiers

Comparing national dementia plans and strategies in Europe – is there a focus of care for people with dementia from a migration background? BMC Public Health

The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks Frontiers

The SARS-CoV-2 vaccination rate and hesitation in Shanghai older adults with dementia Frontiers

Trajectories of Occupational Cognitive Demands and Risk of Mild Cognitive Impairment and Dementia in Later Life Neurology® Journals

North Macedonia interprofessional dementia care (NOMAD) – personalized care plans for people with dementia and caregiver psychoeducation delivered at home by interprofessional teams Frontiers

Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience Frontiers

Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system BMC Public Health

A quasi-experimental mixed-method pilot study to check the efficacy of the “SOUND” active and passive music-based intervention on mental wellbeing and residual cognition of older people with dementia and dementia professionals’ burnout: a research proto Frontiers

Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci Nature

Technological Applications Contributing to Relieve Care Burden or to Sleep of Caregivers and People With Dementia: A Scoping Review From the Perspective of Social Isolation Frontiers

Euthanasia in Dementia: A Narrative Review of Legislation and Practices in the Netherlands and Belgium Frontiers

Mayo Clinic Minute: Is Alzheimer’s Type 3 diabetes? Mayo Clinic News Network

Alzheimer's disease - Lane - 2018 - European Journal of Neurology Wiley Online Library

Relationship between the severity of agitation and quality of life in residents with dementia living in German nursing homes - a secondary data analysis BMC Psychiatry

On our plate today: Healthy and sustainable food choices Friends of Europe